2013 has been a difficult
year for many in the group, which makes it all the more remarkable that it was
one of the most productive on record. In this era of ‘early view’ of papers I’m
not as yet sure of the precise number, but it will be at least 12 peer review
publications for 2013.
Work on protein modification
featured again very heavily in the year and the group has a long-standing
interest in the bacterial protein apo-Neocarzinostatin, an intriguing system,
that has potential as a drug delivery system. Paul Moody, a joint student with
NIMR, completed a painstaking study on the ability of modified NCS constructs to undergo internalisation in
mammalian cells (PEDS)
In another collaborative
study with Derek Macmillan, in UCL Chemistry, Rachel Morgan generated a variety of ubiquitin cysteine mutants that were studied in
order to develop an exciting approach to c-terminally labelled proteins (Angew Chemie).
A key area of current
research for the lab is in in reversible chemical modification of proteins
employing cysteine modification and in 2013 excellent progress was again made. Early
in the year we published a full paper in OBC describing a detailed study on the use of bromomaleiimide agents. Amongst the many practical observations made in this
paper – we were delighted with the finding that we could reverse the
modification using a bis-thiol under mild conditions.
We were also very pleased
with a new approach to dual labelling which followed on from extensive work
pioneered by Ramiz Nathani and Paul Moody. In a paper in Chemical Science, they
described their fndings that a double cysteine mutant of superfolder GFP,
showed differential reactivity. Thus it was possible to install two different
functional groups onto two cysteines present in a protein.
The other main thrust of our
lab is in the area of antibody modification in a close and very productive
collaboration with the Baker group. In
a very detailed study in conjunction with a number of colleagues across UCL, a
new approach to monitoring antibody-antigen interactions was described in Scientific Reports. Felix
Schumacher and Vischel Sanchania developed spinostics, an approach which relies on the
installation of an EPR probe – via disulphide insertion – and then monitoring
using EPR.
Much of the work we do on
protein and antibody modification is reliant on developing effective linker
systems and we were delighted to disclose a new acid cleavable linker system in Chemical Communications. Pioneered by Mark Smith and Lourdes Castenada
the new thiomaleamic acid linker was designed
so that it was stable at physiological pH and temperature, but
quantitatively cleaves at lysosomal pH to release the drug payload. The
strategy was illustrated using by insertion of the novel linker into the single
interchain disulfide bond of a trastuzumab Fab fragment.
One of the key requirements
for our protein and antibody work, is effective methods for making the most
effective small molecules for attachment to biomolecules and a series of new
and mild synthetic protocols for the synthesis of modified maleimides and
pyridizadine-diones were also described this year.
But not all of our work was
on proteins and antibodies. We continued our very productive collaboration with
Frank King on heterocyclic chemistry.
This year we published a number of exciting acid mediated cyclisation
methods for benzyl-cinnamanilides and naphthylamines providing access to
interesting and novel multi-cyclic heterocycles.
Remaining with the field of
cyclisations, Joao Nunes completed a detailed study related to our long
standing interest in furanones, pyranones and cyclopentenones. Joao showed that
depending on precise reaction conditions it is possible to access a very wide
range of 2,4-disubstituted cyclopentenones using very practical synthetic
techniques.
It was also gratifying to
see the continue progress on our “clean” hydroacylation technology originally
published in Nature Chemistry in 2010. This is a remarkable reaction in which we promote the
coupling of an aldehyde with an unsaturated system – with no metals or other
reagents – simply air! In the most
recent paper Vijay, the pioneer of this area – published a full account of thework, including application of the products to the synthesis of gamma-keto-sulfonamides,
sultams, sultones, cyclic N-sulfonyl imines and amides.
So its been a busy and productive year and already 2014 looks set to be
as busy. We already have 5 publications for 2014 with one more submitted. As
ever its been a privilege to work with my talented and inspiring research group,
and I am very grateful to them for all the hard work – and am looking forward
to a great 2014.
No comments:
Post a Comment